News

  • 24 May 2018

    NIH starts Phase l trial of mAb114 to treat Ebola

    The US National Institutes of Health’s (NIH) Clinical Center in Bethesda, Maryland, US, has started the VRC 608 Phase l clinical trial to evaluate the safety and tolerability of mAb114...

  • 23 May 2018

    Nabriva reports positive topline results from LEAP 2 trial

    Nabriva Therapeutics has reported positive topline results from its Lefamulin Evaluation Against Pneumonia (LEAP 2) clinical trial, which examined the safety and efficacy of lefamulin against oral moxifloxacin in adult...

  • 22 May 2018

    Dendreon Pharmaceuticals to begin new trial of Provenge

    Dendreon Pharmaceuticals is set to conduct the new ProVent clinical trial to examine the effectiveness of Provenge (sipuleucel-T) in preventing disease progression in men with prostate cancer on active surveillance...